OP022 Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST studyStefan Schreiber, Ana P. Lacerda, Alessandro Armuzzi et al.|Journal of Crohn s and Colitis|2018Cited by 14
Sa1755 - Rapidity of Clinical and Laboratory Improvements Following Upadacitinib Induction Treatment: Data from the Celest StudyStefan Schreiber, Ana P. Lacerda, Laurent Peyrin‐Biroulet et al.|Gastroenterology|2018Cited by 1